Skip to main content

Gray Nancy Ryan

No open-market purchases or sales filed in the past year.

Current role at each company

  • LGNDLigand Pharmaceuticals IncDirectoras of Jun 9, 2026

Open-market trades in the past year

Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.

Bought
–
0 filings
Sold
–
0 filings
Net
–
Bought minus sold
Companies
0
With open-market trades

Trades

Every Form 4 that lists Gray Nancy Ryan as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Nov 12, 2025 (view filing)Nov 75 daysGray Nancy RyanDirectorSSale−6.57K$205.45−$1.35M−44.8%8.09K after2 lots
May 17, 2024 (view filing)May 98 daysLateGray Nancy RyanDirectorSSale−934$83.20−$77.7K−14.2%5.63K after